INS and metabolic syndrome: A lack of sex steroid may lead to delay of puberty, reduced bone density and size, obesity, impaired insulin sensitivity, and increased risk of dyslipidemia, hypertension, metabolic syndrome and cardiovascular diseases (6–9).